Palvella Therapeutics PVLA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's common stock?
- Palvella Therapeutics (PVLA) reported common stock of $14K in Q1 2026.
- How has Palvella Therapeutics's common stock changed year-over-year?
- Palvella Therapeutics's common stock increased by 27.3% year-over-year, from $11K to $14K.
- What is the long-term trend for Palvella Therapeutics's common stock?
- Over 5 years (2020 to 2025), Palvella Therapeutics's common stock has grown at a -26.5% compound annual growth rate (CAGR), from $56K to $12K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).